MannKind | Spese Operative



Operating Expenses Cambiamento Data
Adma Biologics USD 80.47M 268K 2024-12
Dynavax Technologies USD 91.79M 18.13M 2025-03
Eli Lilly USD 7.32B 1.06B 2025-03
Halozyme Therapeutics USD 123.33M 819K 2025-03
Insmed USD 340.96M 6.11M 2025-03
MacroGenics USD 35.94M 20.58M 2024-12
MannKind USD 56.06M 7.61M 2025-03
Merck USD 9.44B 217M 2025-06
Novo Nordisk DKK 39.3B 1.81B 2025-03
Pfizer USD 10.05B 8.12B 2025-03
Sanofi EUR 8.32B 1.55B 2025-03
Xencor USD 75.91M 9.94M 2025-03


MannKind Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.